Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 162
Infectious Diseases Drugs 123
Genomics 101
Liver and Kidney Disorders Drugs 68
Immune Disorders Drugs 61
Pharmaceuticals 51
Drug Discovery 48
Cardiovascular Drugs 44
Biopharmaceuticals 42
Biotechnology 41
Leukemia Drugs 36
HIV/AIDS Drugs 35
Lymphoma Drugs 29
Clinical Trials 28
Musculoskeletal Disorders Drugs 27
Allergy and Immunology 26
Enzymes 26
Respiratory Drugs 25
Oncology 22
Pulmonary Medicine 20
Central Nervous System Drugs 20
Drug Delivery 19
Infusions and Injectables 17
Pharmaceutical Manufacturing 17
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Drugs by Therapeutic Area 6
Women's Health 6
Lung Cancer Drugs 6
Company Reports 5
Hepatology 5
Colon Cancer Drugs 5
Analgesics 5
Biomarkers 5
Nanomedicine 5
Cervical Cancer Drugs 4
Anesthetic Drugs 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Liver Cancer Drugs 3
Generic Drugs 3
Bladder Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Needles and Syringes 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
E-Healthcare 2
Pharmacoeconomics 2
Prostate Cancer Drugs 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Pediatrics 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



283 reviews

1,018 Results (Page 25 of 51)
- Relevance
  Sort by

Leukemia Targeted Therapy Drugs Market - Global Forecast 2025-2030

 Report
August 2025
186 Pages
Global

From

€3207EUR$3,545USD£2,746GBP

€3563EUR$3,939USD£3,052GBP

Myelodysplastic Syndrome Drug Market - Global Forecast 2025-2030

 Report
August 2025
189 Pages
Global

From

€3207EUR$3,545USD£2,746GBP

€3563EUR$3,939USD£3,052GBP

Non-Hodgkin Lymphoma Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

 Report
November 2025
187 Pages
Global

From

€4071EUR$4,500USD£3,486GBP

Alcohol Use Disorder - Pipeline Insight, 2026

 Clinical Trials
May 2026
80 Pages
Global

From

€1809EUR$2,000USD£1,549GBP

Autoimmune Collaboration and Licensing Deals 2016-2026

 Report
April 2026
500 Pages +
Global

From

€3614EUR$3,995USD£3,095GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Hairy Cell Leukemia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
185 Pages
Global

From

€4071EUR$4,500USD£3,486GBP

Multiple Myeloma Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Global CAR T-Cell Therapy Market 2030 by Drug type, Indication, Target Antigen, End-user and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints

 Report
August 2023
180 Pages
Global

From

€3392EUR$3,750USD£2,905GBP

Leukemia Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4062EUR$4,490USD£3,478GBP

Therapeutics for Women's Health: Technologies and Global Markets

 Report
March 2025
159 Pages
Global

From

€4207EUR$4,650USD£3,602GBP

Halothane Market - Global Forecast to 2030

 Report
August 2025
183 Pages
Global

From

€3207EUR$3,545USD£2,746GBP

€3563EUR$3,939USD£3,052GBP

Biotechnology in the US - Market Research Report 2015-2030

 Report
March 2025
51 Pages
United States

From

€1090EUR$1,205USD£934GBP

Breast Adenocarcinoma Treatment - Global Strategic Business Report

 Report
July 2026
294 Pages
Global

From

€5292EUR$5,850USD£4,532GBP

Head and Neck Squamous Cell Carcinoma - Global Strategic Business Report

 Report
July 2026
917 Pages
Global

From

€5292EUR$5,850USD£4,532GBP

Esophageal Squamous Cell Carcinoma Market - Global Strategic Business Report

 Report
July 2026
275 Pages
Global

From

€5292EUR$5,850USD£4,532GBP

Myelodysplastic Syndrome - Pipeline Review, H1 2020

 Drug Pipelines
June 2020
1667 Pages
Global

From

€1809EUR$2,000USD£1,549GBP

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
240 Pages
Global

From

€2714EUR$3,000USD£2,324GBP

Diffuse Large B-cell Lymphoma Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

 Report
May 2026
180 Pages
Global

From

€4071EUR$4,500USD£3,486GBP

Immunology Market - Global Strategic Business Report

 Report
July 2026
374 Pages
Global

From

€5292EUR$5,850USD£4,532GBP

1,018 Results (Page 25 of 51)
- 1
- 23
- 24
- 25
- 26
- 27

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.